Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

5.10
Delayed Data
As of Jun 22
 +0.02 / +0.39%
Today’s Change
4.86
Today|||52-Week Range
7.09
0.00%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close5.08
Today’s open5.15
Day’s range5.02 - 5.22
Volume6,220
Average volume (3 months)6,236
Market cap$130.4M
Dividend yield--
Data as of 3:20pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)-13.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-41.23%
P/E ratio--
Price/Sales19.81
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+0.01+0.31%
ADVMAdverum Biotechnolog...-0.15-5.00%
PSTIPluristem Therapeuti...+0.01+0.72%
VBLTVascular Biogenics L...-0.10-2.02%
Data as of 3:59pm ET, 06/22/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.6M
Net profit margin-299.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Hamerkaz

Forecasts